Stock Analysis
- Poland
- /
- Medical Equipment
- /
- WSE:MMD
Milestone Medical Third Quarter 2023 Earnings: US$0.035 loss per share (vs US$0.044 loss in 3Q 2022)
Milestone Medical (WSE:MMD) Third Quarter 2023 Results
Key Financial Results
- Net loss: US$764.9k (loss narrowed by 21% from 3Q 2022).
- US$0.035 loss per share (improved from US$0.044 loss in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Milestone Medical shares are up 3.9% from a week ago.
Risk Analysis
You should learn about the 6 warning signs we've spotted with Milestone Medical.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:MMD
Milestone Medical
Milestone Medical, Inc. develops, manufactures, commercializes, and markets intra-articular and epidural drug delivery systems in the United States and Europe.